Nuclear Medicine Equipment Market By Product (Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), By Application (Oncology, Neurology, Cardiology, Other Applications), By End User (Hospitals, Imaging Centers, Academic

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,961	186 Pages	Allied Market Research	May, 2022	ALMR17334462

Best Price Guarantee
Price	from $3,961
Length	186 Pages
Publisher	Allied Market Research
Published Date	May, 2022
SKU	ALMR17334462

Nuclear Medicine Equipment Market By Product (Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), By Application (Oncology, Neurology, Cardiology, Other Applications), By End User (Hospitals, Imaging Centers, Academic and Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2030

Nuclear medicine equipment utilizes radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnose and treat various diseases. This equipment provides images by capturing the radiation from these radioactive medicines. This technique is used for the early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine the immediate response to therapeutic interventions

The key factors that drives the growth of the market are an increase in the prevalence of cancer, heart-related diseases, and neurological disorders has increased the importance of early disease diagnosis, which is expected to positively impact the market growth. The growth of the nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in the adoption of nuclear medicine equipment, and the emergence of innovative & advanced equipment. However, high cost of this equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth. In addition, the key players in the industry have adopted product launch as their key developmental strategy to expand their market foothold. For instance, in November 2016, Philips launched an advanced visual analysis and quantification platform called IntelliSpace Portal 9.0., which assisted radiologists to diagnose and monitor the treatment of neurological diseases, such as multiple sclerosis and dementia.

The nuclear medicine equipment market is segmented on the basis of product type , application, end user, and region. Depending on product, the market is bifurcated into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). SPECT segment is fragmented into standalone and hybrid SPECT, while PET into standalone and hybrid PET. By application, the market is categorized into cardiology, neurology, oncology, and others. By end user, it is classified into hospitals, imaging centers, and academic & research institutes. Region-wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).

The key players in the global nuclear medicine equipment market include General Electric Company, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Digirad Corporation, Mediso Medical Imaging Systems, Ltd., Toshiba Corporation, Bozlu Holding, Neusoft Corporation, Compañía Mexicana de Radiología CGR, S.A de C.V., and SurgicEye GmbH.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nuclear medicine equipment market analysis from 2020 to 2030 to identify the prevailing nuclear medicine equipment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the nuclear medicine equipment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global nuclear medicine equipment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Single-Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)

By Application

Oncology
Neurology
Cardiology
Other Applications

By End User

Hospitals
Imaging Centers
Academic and Research Institutes

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Simen Healthineers
Fujifilm Holdings
Canon Inc
Digirad Corporation
Mediso Medical Imaging Systems
SurgicEye GmbH
General Electric Company
Koninklijke Philips N.V.
bozlu holding
Nuerosoft Medical Systems

CHAPTER 1:INTRODUCTION: 1.1.Report description; 1.2.Key market segments; 1.3.Key benefits to the stakeholders; 1.4.Research Methodology; 1.4.1.Secondary research; 1.4.2.Primary research; 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY: 2.1.Key findings of the study; 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW: 3.1.Market definition and scope; 3.2.Key findings; 3.2.1.Top investment pockets; 3.3.Porter’s five forces analysis; 3.4.Top player positioning; 3.5.Market dynamics; 3.5.1.Drivers; 3.5.2.Restraints; 3.5.3.Opportunities; 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT: 4.1 Overview; 4.1.1 Market size and forecast; 4.2 Single-Photon Emission Computed Tomography (SPECT); 4.2.1 Key market trends, growth factors and opportunities; 4.2.2 Market size and forecast, by region; 4.2.3 Market analysis by country; 4.3 Positron Emission Tomography (PET); 4.3.1 Key market trends, growth factors and opportunities; 4.3.2 Market size and forecast, by region; 4.3.3 Market analysis by country
CHAPTER 5: NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION: 5.1 Overview; 5.1.1 Market size and forecast; 5.2 Oncology; 5.2.1 Key market trends, growth factors and opportunities; 5.2.2 Market size and forecast, by region; 5.2.3 Market analysis by country; 5.3 Neurology; 5.3.1 Key market trends, growth factors and opportunities; 5.3.2 Market size and forecast, by region; 5.3.3 Market analysis by country; 5.4 Cardiology; 5.4.1 Key market trends, growth factors and opportunities; 5.4.2 Market size and forecast, by region; 5.4.3 Market analysis by country; 5.5 Other Applications; 5.5.1 Key market trends, growth factors and opportunities; 5.5.2 Market size and forecast, by region; 5.5.3 Market analysis by country
CHAPTER 6: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER: 6.1 Overview; 6.1.1 Market size and forecast; 6.2 Hospitals; 6.2.1 Key market trends, growth factors and opportunities; 6.2.2 Market size and forecast, by region; 6.2.3 Market analysis by country; 6.3 Imaging Centers; 6.3.1 Key market trends, growth factors and opportunities; 6.3.2 Market size and forecast, by region; 6.3.3 Market analysis by country; 6.4 Academic and Research Institutes; 6.4.1 Key market trends, growth factors and opportunities; 6.4.2 Market size and forecast, by region; 6.4.3 Market analysis by country
CHAPTER 7: NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION: 7.1 Overview; 7.1.1 Market size and forecast; 7.2 North America; 7.2.1 Key trends and opportunities; 7.2.2 North America Market size and forecast, by Product; 7.2.3 North America Market size and forecast, by Application; 7.2.4 North America Market size and forecast, by End User; 7.2.5 North America Market size and forecast, by country; 7.2.5.1 U.S.; 7.2.5.1.1 Market size and forecast, by Product; 7.2.5.1.2 Market size and forecast, by Application; 7.2.5.1.3 Market size and forecast, by End User; 7.2.5.2 Canada; 7.2.5.2.1 Market size and forecast, by Product; 7.2.5.2.2 Market size and forecast, by Application; 7.2.5.2.3 Market size and forecast, by End User; 7.2.5.3 Mexico; 7.2.5.3.1 Market size and forecast, by Product; 7.2.5.3.2 Market size and forecast, by Application; 7.2.5.3.3 Market size and forecast, by End User; 7.3 Europe; 7.3.1 Key trends and opportunities; 7.3.2 Europe Market size and forecast, by Product; 7.3.3 Europe Market size and forecast, by Application; 7.3.4 Europe Market size and forecast, by End User; 7.3.5 Europe Market size and forecast, by country; 7.3.5.1 Germany; 7.3.5.1.1 Market size and forecast, by Product; 7.3.5.1.2 Market size and forecast, by Application; 7.3.5.1.3 Market size and forecast, by End User; 7.3.5.2 France; 7.3.5.2.1 Market size and forecast, by Product; 7.3.5.2.2 Market size and forecast, by Application; 7.3.5.2.3 Market size and forecast, by End User; 7.3.5.3 U.K.; 7.3.5.3.1 Market size and forecast, by Product; 7.3.5.3.2 Market size and forecast, by Application; 7.3.5.3.3 Market size and forecast, by End User; 7.3.5.4 Italy; 7.3.5.4.1 Market size and forecast, by Product; 7.3.5.4.2 Market size and forecast, by Application; 7.3.5.4.3 Market size and forecast, by End User; 7.3.5.5 Spain; 7.3.5.5.1 Market size and forecast, by Product; 7.3.5.5.2 Market size and forecast, by Application; 7.3.5.5.3 Market size and forecast, by End User; 7.3.5.6 Rest of Europe; 7.3.5.6.1 Market size and forecast, by Product; 7.3.5.6.2 Market size and forecast, by Application; 7.3.5.6.3 Market size and forecast, by End User; 7.4 Asia-Pacific; 7.4.1 Key trends and opportunities; 7.4.2 Asia-Pacific Market size and forecast, by Product; 7.4.3 Asia-Pacific Market size and forecast, by Application; 7.4.4 Asia-Pacific Market size and forecast, by End User; 7.4.5 Asia-Pacific Market size and forecast, by country; 7.4.5.1 Japan; 7.4.5.1.1 Market size and forecast, by Product; 7.4.5.1.2 Market size and forecast, by Application; 7.4.5.1.3 Market size and forecast, by End User; 7.4.5.2 China; 7.4.5.2.1 Market size and forecast, by Product; 7.4.5.2.2 Market size and forecast, by Application; 7.4.5.2.3 Market size and forecast, by End User; 7.4.5.3 Australia; 7.4.5.3.1 Market size and forecast, by Product; 7.4.5.3.2 Market size and forecast, by Application; 7.4.5.3.3 Market size and forecast, by End User; 7.4.5.4 India; 7.4.5.4.1 Market size and forecast, by Product; 7.4.5.4.2 Market size and forecast, by Application; 7.4.5.4.3 Market size and forecast, by End User; 7.4.5.5 South Korea; 7.4.5.5.1 Market size and forecast, by Product; 7.4.5.5.2 Market size and forecast, by Application; 7.4.5.5.3 Market size and forecast, by End User; 7.4.5.6 Rest Of Asia Pacific; 7.4.5.6.1 Market size and forecast, by Product; 7.4.5.6.2 Market size and forecast, by Application; 7.4.5.6.3 Market size and forecast, by End User; 7.5 LAMEA; 7.5.1 Key trends and opportunities; 7.5.2 LAMEA Market size and forecast, by Product; 7.5.3 LAMEA Market size and forecast, by Application; 7.5.4 LAMEA Market size and forecast, by End User; 7.5.5 LAMEA Market size and forecast, by country; 7.5.5.1 Brazil; 7.5.5.1.1 Market size and forecast, by Product; 7.5.5.1.2 Market size and forecast, by Application; 7.5.5.1.3 Market size and forecast, by End User; 7.5.5.2 Saudi Arabia; 7.5.5.2.1 Market size and forecast, by Product; 7.5.5.2.2 Market size and forecast, by Application; 7.5.5.2.3 Market size and forecast, by End User; 7.5.5.3 South Africa; 7.5.5.3.1 Market size and forecast, by Product; 7.5.5.3.2 Market size and forecast, by Application; 7.5.5.3.3 Market size and forecast, by End User; 7.5.5.4 Rest of LAMEA; 7.5.5.4.1 Market size and forecast, by Product; 7.5.5.4.2 Market size and forecast, by Application; 7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE: 8.1. Introduction; 8.2. Top winning strategies; 8.3. Product Mapping of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Key developments
CHAPTER 9: COMPANY PROFILES: 9.1 Simen Healthineers; 9.1.1 Company overview; 9.1.2 Company snapshot; 9.1.3 Operating business segments; 9.1.4 Product portfolio; 9.1.5 Business performance; 9.1.6 Key strategic moves and developments; 9.2 Fujifilm Holdings; 9.2.1 Company overview; 9.2.2 Company snapshot; 9.2.3 Operating business segments; 9.2.4 Product portfolio; 9.2.5 Business performance; 9.2.6 Key strategic moves and developments; 9.3 Canon Inc; 9.3.1 Company overview; 9.3.2 Company snapshot; 9.3.3 Operating business segments; 9.3.4 Product portfolio; 9.3.5 Business performance; 9.3.6 Key strategic moves and developments; 9.4 Digirad Corporation; 9.4.1 Company overview; 9.4.2 Company snapshot; 9.4.3 Operating business segments; 9.4.4 Product portfolio; 9.4.5 Business performance; 9.4.6 Key strategic moves and developments; 9.5 Mediso Medical Imaging Systems; 9.5.1 Company overview; 9.5.2 Company snapshot; 9.5.3 Operating business segments; 9.5.4 Product portfolio; 9.5.5 Business performance; 9.5.6 Key strategic moves and developments; 9.6 SurgicEye GmbH; 9.6.1 Company overview; 9.6.2 Company snapshot; 9.6.3 Operating business segments; 9.6.4 Product portfolio; 9.6.5 Business performance; 9.6.6 Key strategic moves and developments; 9.7 General Electric Company; 9.7.1 Company overview; 9.7.2 Company snapshot; 9.7.3 Operating business segments; 9.7.4 Product portfolio; 9.7.5 Business performance; 9.7.6 Key strategic moves and developments; 9.8 Koninklijke Philips N.V.; 9.8.1 Company overview; 9.8.2 Company snapshot; 9.8.3 Operating business segments; 9.8.4 Product portfolio; 9.8.5 Business performance; 9.8.6 Key strategic moves and developments; 9.9 bozlu holding; 9.9.1 Company overview; 9.9.2 Company snapshot; 9.9.3 Operating business segments; 9.9.4 Product portfolio; 9.9.5 Business performance; 9.9.6 Key strategic moves and developments; 9.10 Nuerosoft Medical Systems; 9.10.1 Company overview; 9.10.2 Company snapshot; 9.10.3 Operating business segments; 9.10.4 Product portfolio; 9.10.5 Business performance; 9.10.6 Key strategic moves and developments
LIST OF TABLES: TABLE 1. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 2. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION , 2020-2030,($MILLION); TABLE 3. NUCLEAR MEDICINE EQUIPMENT MARKET FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) BY COUNTRY, 2020-2030,($MILLION); TABLE 4. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR POSITRON EMISSION TOMOGRAPHY (PET), BY REGION , 2020-2030,($MILLION); TABLE 5. NUCLEAR MEDICINE EQUIPMENT MARKET FOR POSITRON EMISSION TOMOGRAPHY (PET) BY COUNTRY, 2020-2030,($MILLION); TABLE 6. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 7. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR ONCOLOGY, BY REGION , 2020-2030,($MILLION); TABLE 8. NUCLEAR MEDICINE EQUIPMENT MARKET FOR ONCOLOGY BY COUNTRY, 2020-2030,($MILLION); TABLE 9. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR NEUROLOGY, BY REGION , 2020-2030,($MILLION); TABLE 10. NUCLEAR MEDICINE EQUIPMENT MARKET FOR NEUROLOGY BY COUNTRY, 2020-2030,($MILLION); TABLE 11. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR CARDIOLOGY, BY REGION , 2020-2030,($MILLION); TABLE 12. NUCLEAR MEDICINE EQUIPMENT MARKET FOR CARDIOLOGY BY COUNTRY, 2020-2030,($MILLION); TABLE 13. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR OTHER APPLICATIONS, BY REGION , 2020-2030,($MILLION); TABLE 14. NUCLEAR MEDICINE EQUIPMENT MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2020-2030,($MILLION); TABLE 15. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 16. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION); TABLE 17. NUCLEAR MEDICINE EQUIPMENT MARKET FOR HOSPITALS BY COUNTRY, 2020-2030,($MILLION); TABLE 18. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR IMAGING CENTERS, BY REGION , 2020-2030,($MILLION); TABLE 19. NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING CENTERS BY COUNTRY, 2020-2030,($MILLION); TABLE 20. NUCLEAR MEDICINE EQUIPMENT MARKET REVENUE, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION , 2020-2030,($MILLION); TABLE 21. NUCLEAR MEDICINE EQUIPMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTES BY COUNTRY, 2020-2030,($MILLION); TABLE 22. NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION, 2020-2030,($MILLION); TABLE 23. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 24. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 25. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 26. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2020-2030,($MILLION); TABLE 27. U.S. NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 28. U.S. NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 29. U.S. NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 30. CANADA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 31. CANADA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 32. CANADA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 33. MEXICO NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 34. MEXICO NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 35. MEXICO NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 36. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 37. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 38. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 39. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2020-2030,($MILLION); TABLE 40. GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 41. GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 42. GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 43. FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 44. FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 45. FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 46. U.K. NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 47. U.K. NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 48. U.K. NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 49. ITALY NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 50. ITALY NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 51. ITALY NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 52. SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 53. SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 54. SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 55. REST OF EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 56. REST OF EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 57. REST OF EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 58. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 59. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 60. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 61. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2020-2030,($MILLION); TABLE 62. JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 63. JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 64. JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 65. CHINA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 66. CHINA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 67. CHINA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 68. AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 69. AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 70. AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 71. INDIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 72. INDIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 73. INDIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 74. SOUTH KOREA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 75. SOUTH KOREA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 76. SOUTH KOREA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 77. REST OF ASIA PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 78. REST OF ASIA PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 79. REST OF ASIA PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 80. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 81. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 82. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 83. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2020-2030,($MILLION); TABLE 84. BRAZIL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 85. BRAZIL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 86. BRAZIL NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 87. SAUDI ARABIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 88. SAUDI ARABIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 89. SAUDI ARABIA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 90. SOUTH AFRICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 91. SOUTH AFRICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 92. SOUTH AFRICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 93. REST OF LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT, 2020-2030,($MILLION); TABLE 94. REST OF LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2020-2030,($MILLION); TABLE 95. REST OF LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2020-2030,($MILLION); TABLE 96.SIMEN HEALTHINEERS: COMPANY SNAPSHOT; TABLE 97.SIMEN HEALTHINEERS: OPERATING SEGMENTS; TABLE 98.SIMEN HEALTHINEERS: PRODUCT PORTFOLIO; TABLE 99.SIMEN HEALTHINEERS: NET SALES,; TABLE 100.SIMEN HEALTHINEERS: KEY STRATERGIES; TABLE 101.FUJIFILM HOLDINGS: COMPANY SNAPSHOT; TABLE 102.FUJIFILM HOLDINGS: OPERATING SEGMENTS; TABLE 103.FUJIFILM HOLDINGS: PRODUCT PORTFOLIO; TABLE 104.FUJIFILM HOLDINGS: NET SALES,; TABLE 105.FUJIFILM HOLDINGS: KEY STRATERGIES; TABLE 106.CANON INC: COMPANY SNAPSHOT; TABLE 107.CANON INC: OPERATING SEGMENTS; TABLE 108.CANON INC: PRODUCT PORTFOLIO; TABLE 109.CANON INC: NET SALES,; TABLE 110.CANON INC: KEY STRATERGIES; TABLE 111.DIGIRAD CORPORATION: COMPANY SNAPSHOT; TABLE 112.DIGIRAD CORPORATION: OPERATING SEGMENTS; TABLE 113.DIGIRAD CORPORATION: PRODUCT PORTFOLIO; TABLE 114.DIGIRAD CORPORATION: NET SALES,; TABLE 115.DIGIRAD CORPORATION: KEY STRATERGIES; TABLE 116.MEDISO MEDICAL IMAGING SYSTEMS: COMPANY SNAPSHOT; TABLE 117.MEDISO MEDICAL IMAGING SYSTEMS: OPERATING SEGMENTS; TABLE 118.MEDISO MEDICAL IMAGING SYSTEMS: PRODUCT PORTFOLIO; TABLE 119.MEDISO MEDICAL IMAGING SYSTEMS: NET SALES,; TABLE 120.MEDISO MEDICAL IMAGING SYSTEMS: KEY STRATERGIES; TABLE 121.SURGICEYE GMBH: COMPANY SNAPSHOT; TABLE 122.SURGICEYE GMBH: OPERATING SEGMENTS; TABLE 123.SURGICEYE GMBH: PRODUCT PORTFOLIO; TABLE 124.SURGICEYE GMBH: NET SALES,; TABLE 125.SURGICEYE GMBH: KEY STRATERGIES; TABLE 126.GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT; TABLE 127.GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS; TABLE 128.GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO; TABLE 129.GENERAL ELECTRIC COMPANY: NET SALES,; TABLE 130.GENERAL ELECTRIC COMPANY: KEY STRATERGIES; TABLE 131.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT; TABLE 132.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS; TABLE 133.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO; TABLE 134.KONINKLIJKE PHILIPS N.V.: NET SALES,; TABLE 135.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES; TABLE 136.BOZLU HOLDING: COMPANY SNAPSHOT; TABLE 137.BOZLU HOLDING: OPERATING SEGMENTS; TABLE 138.BOZLU HOLDING: PRODUCT PORTFOLIO; TABLE 139.BOZLU HOLDING: NET SALES,; TABLE 140.BOZLU HOLDING: KEY STRATERGIES; TABLE 141.NUEROSOFT MEDICAL SYSTEMS: COMPANY SNAPSHOT; TABLE 142.NUEROSOFT MEDICAL SYSTEMS: OPERATING SEGMENTS; TABLE 143.NUEROSOFT MEDICAL SYSTEMS: PRODUCT PORTFOLIO; TABLE 144.NUEROSOFT MEDICAL SYSTEMS: NET SALES,; TABLE 145.NUEROSOFT MEDICAL SYSTEMS: KEY STRATERGIES
LIST OF FIGURES: FIGURE 1.NUCLEAR MEDICINE EQUIPMENT MARKET SEGMENTATION; FIGURE 2.NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030; FIGURE 3.NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030; FIGURE 4. TOP INVESTMENT POCKETS, BY REGION; FIGURE 5.PORTER FIVE-1; FIGURE 6.PORTER FIVE-2; FIGURE 7.PORTER FIVE-3; FIGURE 8.PORTER FIVE-4; FIGURE 9.PORTER FIVE-5; FIGURE 10.TOP PLAYER POSITIONING; FIGURE 11.NUCLEAR MEDICINE EQUIPMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES; FIGURE 12.NUCLEAR MEDICINE EQUIPMENT MARKET,BY PRODUCT,2020(%); FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 14.COMPARATIVE SHARE ANALYSIS OF POSITRON EMISSION TOMOGRAPHY (PET) NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 15.NUCLEAR MEDICINE EQUIPMENT MARKET,BY APPLICATION,2020(%); FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 17.COMPARATIVE SHARE ANALYSIS OF NEUROLOGY NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CARDIOLOGY NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHER APPLICATIONS NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 20.NUCLEAR MEDICINE EQUIPMENT MARKET,BY END USER,2020(%); FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 22.COMPARATIVE SHARE ANALYSIS OF IMAGING CENTERS NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND RESEARCH INSTITUTES NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030(%); FIGURE 24.NUCLEAR MEDICINE EQUIPMENT MARKET BY REGION,2020; FIGURE 25.U.S. NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 26.CANADA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 27.MEXICO NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 28.GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 29.FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 30.U.K. NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 31.ITALY NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 32.SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 33.REST OF EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 34.JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 35.CHINA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 36.AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 37.INDIA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 38.SOUTH KOREA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 39.REST OF ASIA PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 40.BRAZIL NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 41.SAUDI ARABIA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 42.SOUTH AFRICA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 43.REST OF LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET,2020-2030($MILLION); FIGURE 44. TOP WINNING STRATEGIES, BY YEAR; FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT; FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY; FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 48.COMPETITIVE DASHBOARD; FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS; FIGURE 50.SIMEN HEALTHINEERS.: NET SALES ,($MILLION); FIGURE 51.FUJIFILM HOLDINGS.: NET SALES ,($MILLION); FIGURE 52.CANON INC.: NET SALES ,($MILLION); FIGURE 53.DIGIRAD CORPORATION.: NET SALES ,($MILLION); FIGURE 54.MEDISO MEDICAL IMAGING SYSTEMS.: NET SALES ,($MILLION); FIGURE 55.SURGICEYE GMBH.: NET SALES ,($MILLION); FIGURE 56.GENERAL ELECTRIC COMPANY.: NET SALES ,($MILLION); FIGURE 57.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION); FIGURE 58.BOZLU HOLDING.: NET SALES ,($MILLION); FIGURE 59.NUEROSOFT MEDICAL SYSTEMS.: NET SALES ,($MILLION)